ADVANCES IN THE DIAGNOSIS PATHOGENESIS AND TREATMENT OF CIDP PDF

Download Citation on ResearchGate | Advances in the diagnosis, pathogenesis and treatment of CIDP | Chronic inflammatory demyelinating. This Review highlights the recent advances in diagnosing CIDP, provides an update on the immunopathology including new target antigens. CIDP is an acquired immune-mediated inflammatory disorder sometimes Advances in the diagnosis, pathogenesis and treatment of CIDP.

Author: Vudodal Arashik
Country: Moldova, Republic of
Language: English (Spanish)
Genre: Life
Published (Last): 24 June 2015
Pages: 286
PDF File Size: 20.20 Mb
ePub File Size: 13.24 Mb
ISBN: 515-2-95645-878-7
Downloads: 32853
Price: Free* [*Free Regsitration Required]
Uploader: Daigore

Dalakas The Lancet Neurology This paper has been referenced on Twitter 1 time over the past 90 days.

Advances in our understanding of the underlying immunopathology in CIDP have identified new targets for future therapeutic efforts, including T cells, B cells, and transmigration and transduction molecules.

References Publications referenced by this paper.

Advances in the diagnosis, pathogenesis and treatment of CIDP.

Armati Journal of the peripheral nervous system: Antonis FanouriakisDimitrios T. Evidence from Human and Animal Studies: Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy Marinos C. BoumpasGeorge K.

Current diagnosis of CIDP: Pathogenesis and treatment of CNS lupus. Despite clinical challenges in diagnosis—owing in part to the existence of disease variants, and different views on how many electrophysiological abnormalities are needed to document demyelination—consensus criteria seem to have been reached for research or clinical practice.

  KRYSIAK SIECI KOMPUTEROWE KOMPENDIUM PDF

Advances in the diagnosis, pathogenesis and treatment of CIDP

Showing of references. This Review highlights the recent advances in diagnosing CIDP, provides an update on the immunopathology including new target antigens, and discusses current treatments, ongoing challenges and future therapeutic directions.

Showing of 60 extracted citations. Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: Bertsias Current opinion in rheumatology Topics Discussed in This Paper. Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy. Chronic inflammatory demyelinating polyneuropathy CIDP is the most common chronic autoimmune neuropathy. Maintenance therapy with IVIg can induce sustained remission, increase quality of life and prevent further axonal loss, but caution is needed to avoid overtreatment.

Advances in the diagnosis, pathogenesis and treatment of CIDP.

New biomarkers and scoring systems represent emerging tools with the potential to predict therapeutic responses and identify patients with active disease for enrollment into clinical trials. By clicking accept or continuing to use the site, you agree to the treatmwnt outlined in our Privacy PolicyTerms of Serviceand Dataset License. MRI assessment including apparent diffusion coefficient.

  ANTWERPEN STADSPLAN PDF

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Search for additional papers on this topic. Commonly used immunosuppressive drugs offer minimal benefit, necessitating the development of new therapies for treatment-refractory patients.

An open label clinical trial of complement inhibition in multifocal motor neuropathy. An update on the management of chronic inflammatory demyelinating polyneuropathy.

Skip to search form Skip diabnosis main content. Despite clinical challenges in diagnosis-owing in part to the existence of disease variants, and different views on how many electrophysiological abnormalities are needed to document demyelination-consensus criteria seem to have been reached for research or clinical practice. Brannagan Journal of the peripheral nervous system: Citations Publications citing this paper. Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Immunoglobulins, Intravenous Demyelinating peripheral neuropathy Polyneuropathy.

Kenneth Craig Gorson Therapeutic advances in neurological disorders Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies. From This Paper Figures, tables, and topics from this paper. John David PollardPatricia J.